Skip to Content
Merck
All Photos(9)

Key Documents

View All Documentation

F0257

Sigma-Aldrich

Anti-Mouse IgG (whole molecule)–FITC antibody produced in goat

affinity isolated antibody, buffered aqueous solution

Synonym(s):

Anti-Mouse Fitc, Anti-Mouse Fitc - Anti-Mouse IgG (whole molecule)–FITC antibody produced in goat

Sign Into View Organizational & Contract Pricing
All Photos(9)

About This Item

MDL number:
MFCD00162642
UNSPSC Code:
12352203
NACRES:
NA.46

biological source

goat

Quality Level

200

conjugate

FITC conjugate

antibody form

affinity isolated antibody

antibody product type

secondary antibodies

clone

polyclonal

form

buffered aqueous solution

technique(s)

direct immunofluorescence: 1:32

storage temp.

2-8°C

target post-translational modification

unmodified

Looking for similar products? Visit Product Comparison Guide

General description

IgG antibody subtype is the most abundant serum immunoglobulins of the immune system. It is secreted by B cells and is found in blood and extracellular fluids and provides protection from infections caused by bacteria, fungi and viruses. Maternal IgG is transferred to foetus through the placenta that is vital for immune defense of the neonate against infections. Mouse IgGs has four distinct isotypes, namely, IgG1, IgG2a, IgG2b, and IgG3.

Immunogen

Purified mouse IgG

Application

Anti-Mouse IgG (whole molecule)-FITC antibody has been used in:
  • immunohistochemistry (1:200) (1:500)
  • immunofluorescence (1:100)(1:500)(1:200)
  • immunocytochemistry(1:1000)

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 1% bovine serum albumin and 15 mM sodium azide.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Specific heat shock proteins protect microtubules during simulated ischemia in cardiac myocytes
Bluhm, W., F., et al.
American Journal of Physiology. Heart and Circulatory Physiology, 275(6), H2243-H2249 (1998)
Shalini S Yadav et al.
Translational oncology, 10(3), 357-366 (2017-03-28)
Prostate cancer (PCa) remains the second-leading cause of cancer-related deaths in American men with an estimated mortality of more than 26,000 in 2016 alone. Aggressive and metastatic tumors are treated with androgen deprivation therapies (ADT); however, the tumors acquire resistance
Yung-I Lee et al.
Annals of botany, 116(3), 403-411 (2015-06-25)
Although abscisic acid (ABA) is commonly recognized as a primary cause of seed dormancy, there is a lack of information on the role of ABA during orchid seed development. In order to address this issue, the localization and quantification of
Maruthachalam Ravi et al.
PLoS genetics, 7(6), e1002121-e1002121 (2011-06-23)
Centromere behavior is specialized in meiosis I, so that sister chromatids of homologous chromosomes are pulled toward the same side of the spindle (through kinetochore mono-orientation) and chromosome number is reduced. Factors required for mono-orientation have been identified in yeast.
Christine A King et al.
Journal of virology, 89(22), 11347-11355 (2015-09-05)
Lytic activation of Kaposi's sarcoma-associated herpesvirus (KSHV) from latency is a critical contributor to pathogenesis and progression of KSHV-mediated disease. Development of targeted treatment strategies and improvement of lytic-phase-directed oncolytic therapies, therefore, hinge on gaining a better understanding of latency-to-lytic-phase
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service